July 12, 2011 Stevensville, Maryland – Vapotherm, a privately held manufacturer of respiratory care devices for hospital and home use, announced today that it has signed a new exclusive distribution agreement with Hippo Medical of Seoul, Korea. Hippo will cover all of Korea for the Vapotherm acute care product line.
“We are pleased to announce this new partnership with Hippo to bring high flow therapy to the Korean market,” said Steve Orwig, Acute Care Manager with Vapotherm. “We had several options for our distribution in Korea, but we ultimately selected Hippo based on the professionalism of their sales and marketing organization and the enthusiasm they share for the large market potential for high flow in the market.”
Hwang Se Jung, Vice President at Hippo Medical commented, “Hippo is pleased to represent the Vapotherm line in Korea, where we see strong potential for high flow therapy. Vapotherm brings us clear clinical and technical leadership in high flow therapy, with innovative products like Precision Flow®, the only device in the category to integrate flow, gas blending and humidification control in one device for cost effective, non-invasive respiratory support via nasal cannula.”
Hippo Medical was founded in 1976 and specializes in importing, marketing and distributing premium, innovative medical technologies to hospitals and clinicians. Their product line includes airway management and other critical care technologies from manufacturers such as Covidien, Medis and Arcomed. For more information, visit www.hippomedical.co.kr.
Vapotherm, Inc. is a privately held manufacturer of respiratory care devices for hospitals and home care use based in Stevensville, Maryland. The Company is dedicated to the development of innovative, noninvasive technologies for respiratory therapy, especially for the treatment of chronic lung and acute breathing disorders. For more information, visit www.vapotherm.com.